دورية أكاديمية
102P Long-term prediction of clinical outcomes by the 21-gene test in HR+ HER2- breast cancer patients with residual disease after neoadjuvant chemotherapy
| العنوان: | 102P Long-term prediction of clinical outcomes by the 21-gene test in HR+ HER2- breast cancer patients with residual disease after neoadjuvant chemotherapy |
|---|---|
| المؤلفون: | Peg, V., de los Ángeles, N., Vieites, B., Bellet, M., Castilla, C., Gomez Pardo, P., Pérez-Luque, A., Lopez, M.A., Salvador Bofill, F.J., Alfaro, L., Perez Garcia, J.M., Espinosa-Bravo, M. |
| المصدر: | Annals of Oncology ; volume 33, page S171-S172 ; ISSN 0923-7534 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2022 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| مصطلحات موضوعية: | Oncology, Hematology |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.annonc.2022.03.118 |
| الإتاحة: | https://doi.org/10.1016/j.annonc.2022.03.118Test https://api.elsevier.com/content/article/PII:S0923753422004975?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S0923753422004975?httpAccept=text/plainTest |
| حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://www.elsevier.com/open-access/userlicense/1.0Test/ |
| رقم الانضمام: | edsbas.AE34CB1A |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.annonc.2022.03.118 |
|---|